Stay updated on Fevipiprant in Patients With Nasal Polyposis and Asthma Clinical Trial
Sign up to get notified when there's something new on the Fevipiprant in Patients With Nasal Polyposis and Asthma Clinical Trial page.

Latest updates to the Fevipiprant in Patients With Nasal Polyposis and Asthma Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check7 days agoChange DetectedA site-wide notice announces NIH’s transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check14 days agoChange DetectedThe footer revision marker changed from v3.7.1 to v3.7.2; the page still displays a 403 error.SummaryDifference0.2%

- Check21 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check42 days agoChange DetectedA 403 Forbidden page now appears when attempting to view the study record, blocking access to the study details. The previous content is replaced by the 403 message along with the site header and footer.SummaryDifference18%

- Check63 days agoChange DetectedThe page adds a funding note for 2018 (U.S. NIH Grant/Contract). The page revision has been updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

Stay in the know with updates to Fevipiprant in Patients With Nasal Polyposis and Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fevipiprant in Patients With Nasal Polyposis and Asthma Clinical Trial page.